Related Experiment Video
Updated: Mar 21, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.5K
A 61-year-old woman develops polyuria after hip revision.
Aisha Shaheen1, Mark Dobish2, Vanessa Gleason3
1Department of Surgery, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, USA.
Journal of Surgical Case Reports
|May 13, 2016
Summary
A patient experienced hearing and vision loss, polyuria, and numbness after hip surgery. These symptoms suggest a potential neurological complication following orthopedic intervention.
Area of Science:
- Neurology
- Ophthalmology
- Audiology
Background:
- A 61-year-old woman with no prior health issues presented with progressive sensory deficits.
- Her medical history included a hip arthroplasty revision and a subsequent closed reduction due to dislocation.
Observation:
- The patient developed polyuria, hearing loss, vision loss, and peripheral numbness.
- These symptoms emerged several weeks after the hip reduction procedure.
Findings:
- The case highlights a potential link between orthopedic procedures and neurological symptoms.
- Progressive sensory and autonomic dysfunction were noted.
Implications:
- This case underscores the importance of considering neurological complications after orthopedic interventions.
- Further investigation is warranted to understand the underlying pathophysiology and establish causality.
Related Concept Videos
01:16Insulin: Dosing Regimen and Adverse Effects
1.1K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.1K
01:06Oral Hypoglycemic Agents: Glinides
921
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
921
01:30Acute Pancreatitis II: Clinical Manifestations and Management
1.0K
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
1.0K
01:15Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
3.0K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
3.0K
01:22Diabetes Mellitus: Type 2 and Gestational
5.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K